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Abstract
Background: Recent research in two cholera-endemic communities of Zanzibar has shown that a majority (,94%) of the
adult population was willing to receive free oral cholera vaccines (OCVs). Since OCV uptake in the 2009 campaign reached
only ,50% in these communities, an evaluation of social and cultural factors and of barriers was conducted to understand
this difference for future cholera control planning.
Methodology/Principal Findings: A random sample of 367 adult peri-urban and rural community residents (46.6%
immunized vs. 53.4% unimmunized) was studied with a semi-structured interview that inquired about social and cultural
features of cholera depicted in a vignette and barriers to OCV uptake. Symptoms (rectal pain, loose skin only in rural
community) and perceived causes (uncovered food, contact with contaminated water) specific for severe diarrhea were
associated with uptake. Purchasing drugs from pharmacies to stop diarrhea and vomiting was negatively associated with
uptake. Increasing household size, age and previous enteric illness episode were positively related to uptake, the latter only
at the rural site. The most prominent barrier to uptake was competing obligations or priorities (reported by 74.5%, identified
as most important barrier by 49.5%). Next most prominent barriers were lacking information about the campaign (29.6%,
12.2%), sickness (14.3%, 13.3%) and fear of possible vaccine side effects (15.3%, 5.6%). The majority of unvaccinated
respondents requested repetition of the vaccination with free OCVs.
Conclusions/Significance: Factors associated with uptake indicated a positive impact of the vaccination campaign and of
sensitization activities on vaccine acceptance behavior. Unlike communities opposed to cholera control or settings where
public confidence in vaccines is lacking, identified barriers to uptake indicated a good campaign implementation and trust
in the health system. Despite prospects and demand for repeating the vaccination, local decision-makers should reconsider
how careful logistical arrangements may improve community coverage and thus effectiveness of vaccination campaigns.
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Introduction
Cholera control in populations living at risk of recurrent cholera
outbreaks is based on timely treatment and prevention strategies,
mainly promoting supply of safe water in sufficient quantities,
improved sanitation, and health education (WASH) [1]. Despite
these recommendations, cholera has remained a global public
health concern; the World Health Organization (WHO) assumes
that annual estimates for morbidity and mortality exceed 3 million
cases and 100,000 deaths [2]. The WHO also recommends the use
of mass oral cholera vaccination as a supplementary prevention
measure to WASH [3].
Cholera is an enteric bacterial disease caused by Vibrio cholerae
serogroup O1 or O139. People living in unsanitary conditions
without access to safe drinking water and sanitation are at greatest
risk of becoming infected with V. cholerae, which is mainly
transmitted through the fecal-oral route. Major clinical features,
which usually start abruptly after an incubation period of a few
hours to five days, include profuse watery diarrhea and vomiting
[4]. Without treatment, case-fatality rates may rise to 50% or
above. Rehydration is the mainstay for treatment and includes
administration of oral rehydration solution (ORS) to patients with
mild to moderate symptoms and intravenous fluids to severely
dehydrated cases. Antibiotics should also be administered to severe
cases to shorten episodes, diminish the amount of intravenous
fluids required and reduce shedding of V. cholerae [2]. Some studies
suggest that antibiotics should also be used for moderate cases [5].
While recent research on the use of oral cholera vaccines
(OCVs) in mass vaccination campaigns in endemic communities
has focused on epidemiologic parameters [6,7] and economic
aspects [8–13], relatively little is known about local perceptions of
cholera, intentions to accept OCVs and how such factors are
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associated with uptake. Even though detailed knowledge of
epidemiologic and economic aspects is indispensable for a
successful introduction of vaccines, social and cultural factors
should also be examined to improve and sustain vaccination
coverage [14,15]. In the past, a lack of attention to community
views of illness and prevention has proven to be fatal not only for
disease control in certain populations but also for national or
international public health goals, e.g., to eradicate polio in Africa
[16,17].
To date, only articles on policymakers’ views of cholera [18,19]
and on social factors of oral cholera vaccine uptake [20] have been
published, and studies on the feasibility and costs of community
mass vaccination campaigns have examined why people might not
have taken the OCV [8,21,22]. However, an assessment of mass
vaccination campaigns to systematically evaluate social and
cultural factors associated with OCV uptake and to identify
potential barriers is still missing, but likely to be very useful for the
benefit of local (and even international) vaccination campaign
planning.
Recent research in two cholera-endemic communities of
Zanzibar, conducted within the framework of a WHO study to
evaluate the use of OCV in endemic settings, has shown that a vast
majority (,94%) of the population targeted for the campaign was
in principle willing to receive free vaccines against cholera [23].
Since actual OCV acceptance (or uptake) reached only ,50% in
this pre-vaccination sample, an evaluation of social and cultural
factors and of barriers to OCV uptake was needed to understand
this difference for future cholera control planning in Zanzibar.
Findings reported here are based on the research approach of
cultural epidemiology, which was used in pre-vaccination studies
to examine social and cultural determinants of anticipated and
actual OCV acceptance [23,24]. Cultural epidemiology [25] is a
research approach in health social sciences based on Arthur
Kleinman’s framework of illness explanatory models [26]. The
approach integrates quantitative and qualitative data to study
community views of illness [27–31] and how these influence
health-related behavior [32–34]. It has been validated in
numerous settings to study mental ill-health, chronic and infectious
diseases and health-related stigma and involves use of culturally
adapted semi-structured interviews to elicit the distribution of
locally valid features of illness-related experience, meaning and
behavior [35].
This study examined data from a peri-urban and a rural
community targeted in the 2009 OCV mass vaccination campaign
in Zanzibar. It aimed to evaluate the influence of social and
cultural factors on OCV uptake and to identify logistical, medical,
social and system-related barriers to uptake, stratified by site and
by gender.
Methods
Ethics statement
The Research Ethics Review Committee of the World Health
Organization and the Ethics Committee of the Ministry of Health
of Zanzibar approved this study. Participants were informed orally
about this study and also given a detailed information sheet. Only
those who gave written consent were interviewed. No compensa-
tion was offered for the interview. Interview data sheets did not
bear the names of respondents and all data were anonymized
before analysis.
Setting
The east African archipelago of Zanzibar belongs to the United
Republic of Tanzania and is inhabited by ,1.2 million people
who are predominantly Muslim. Kiswahili is the main language,
but English is also widely used. The archipelago is located,60 km
off the coast of mainland Tanzania and consists of two major
islands—Unguja in the south and Pemba in the north—and
several islets; it can be reached from the coast by ferry or air within
20 minutes to 2 hours. Zanzibar has been regularly affected by
cholera; the first cases in recent times were detected in 1978
[36,37].
This study was conducted in the peri-urban Shehia of
Chumbuni (population ,11,000) in Unguja and the rural Shehia
of Mwambe (,8,000) in Pemba. Both Shehias (administrative
term for community in Zanzibar) were among the core areas of a
mass vaccination campaign that was conducted in early 2009 by
the Ministry of Health of Zanzibar (MoH) with support from the
WHO. The sample for this study was drawn from these two
Shehias because they had been studied in a pre-vaccination survey
in 2008 [23,24]. The peri-urban site, an unplanned, slum-like
extension of the capital, mainly consists of brick houses and is
characterized by a high population density; the rural site consists
of hamlets and most people live in mud houses. More details of
both sites have been reported elsewhere [24].
Mass vaccination campaign
The mass vaccination campaign aimed to vaccinate ,50,000
inhabitants with DukoralH, a two-dose OCV containing killed V.
cholerae O1 bacteria and recombinant cholera toxin B subunit
protein [38]. DukoralH was the only OCV pre-qualified by the
WHO at the time of vaccination. It requires a cold chain for
storage and safe water (,1.5 dl per dose) for its administration. It
was offered without charge in two rounds from January 17 to 26
and February 7 to 16, 2009, to residents aged two years or older
from six Shehias from Unguja and Pemba that had been identified
as recent cholera hotspots. Nine vaccination posts were set up on
each island that operated daily for at least eight hours and were
staffed with local healthcare workers and villagers.
Information activities for the campaign started with a meeting
with district officials on December 23, 2008, followed by three
meetings to inform leaders, Shehia committee members and
mobilizers from each community (January 5 and 10, 2009) and
general community residents (January 15, 2009) (MoH, Health
Promotion Unit, OCV Social Mobilization Report, February 20,
2009). A refresher meeting in the communities followed shortly
before the second round on February 5, 2009. Social mobilization
used posters, leaflets, street banners and T-shirts to disseminate
information on the OCV campaign and to reinforce general
hygiene and sanitation messages in the six Shehias. Messages were
continuously broadcast on national TV and radio from the first
until the last day of the campaign. The local press was also briefed
and newspaper articles reported from the campaign to promote
participation. The campaign was officially launched by the
Minister of Health who drank the vaccine publicly at the
Chumbuni Primary Healthcare Unit (Zanzibar Today, January 18,
2009). Mobilizer teams were formed for each Shehia and delivered
information from house to house and by megaphone. Each team
consisted of five to six community residents representing also
women’s groups, youth, religious groups and members of the
opposition party. Key messages highlighted not only the impor-
tance of vaccination for cholera prevention, but also promoted
hygiene messages to prevent other diarrheal diseases, and
explained administration of the OCV, its characteristic features
and potential for mild side effects.
Lessons Learned to Improve OCV Community Coverage
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Design and sampling
This was a cross-sectional interview survey based on a case-
control design to identify factors associated with vaccine uptake
among vaccinated and unvaccinated community members target-
ed for the mass vaccination campaign. In addition, unvaccinated
participants were also interviewed about barriers to uptake for site-
and gender-related comparative analysis. Data were collected in
June and July 2009, six months after the mass vaccination
campaign. The sampling frame for this study was derived from the
census database that had been compiled by the International
Vaccine Institute shortly before the mass vaccination campaign
implementation in early 2009 [39]. Names, age, sex, OCV
vaccination status and a unique house identification number were
extracted for both study Shehias. Respondents’ houses in
Chumbuni were located with the help of aerial photographs
indicating house numbers; houses in Mwambe were located with
the help of local assistants.
Approximately 380 adults, based on a sample size of 330 [40]
with 15% compensation for missing data, were identified following
a stratified random sampling procedure. After exclusion of
respondents who had been interviewed before the vaccination
for the baseline study [24], all respondents aged 18 years and older
were selected. Second, peri-urban and rural respondents were
separated and groups of women and men created among them.
Third, of the approximately 95 women and 95 men required per
site, 50% were selected from those who had received two doses of
the OCV, 40% from those who had not received a single dose and
10% from those with one dose only. Only residents who were
physically and mentally fit to stand an interview of approximately
one hour duration were included in the sample. Women who had
not taken the vaccine because of pregnancy during the mass
vaccination campaign were not interviewed.
Instrument
Semi-structured interviews based on the Explanatory Model
Interview Catalogue (EMIC) are the principal instrument for
cultural epidemiological studies and elicit locally valid features of
illness-related experience (operationalized as categories of distress),
meaning (perceived causes) and behavior (help seeking) [25,35].
An EMIC interview for study of diarrhea-free community
residents was developed based on the pre-vaccination survey
[24] (see supporting information, Text S1). A ten-day workshop
was conducted shortly before the survey to train field workers and
pilot the EMIC interview in Shehias adjacent to the study
communities.
After recording relevant socio-demographic characteristics,
interviews began with the telling of a brief story in easily
understandable terms, making use of a clinical vignette that
described a cholera patient with cardinal somatic symptoms. To
study socio-cultural features of cholera-like illness, respondents
were asked a series of open and closed questions. These elicited
patterns of distress (i.e., respondents’ opinions on what additional
physical symptoms the cholera patient described in the vignette
might suffer from, and how the illness might impact him/her
socially, emotionally and financially), perceived causes (i.e., what
causes the illness may be attributed to) and help-seeking behavior
(i.e., what would usually be done at the patient’s home for self
treatment and what sources of help would be consulted outside the
household).
Respondents who did not swallow two doses of the OCV during
the mass vaccination campaign were queried about their reasons
against vaccination by specifically inquiring about barriers related
to logistical, social and system-relevant and medical aspects.
Data management and analysis
Data entry. Quantitative data were recorded by interviewers
on data sheets, double entered in Epi Info 3.5.1 (CDC, Atlanta,
GA, USA) by data entry clerks and cleaned for statistical analysis
in SAS 9.2 (SAS Institute, Cary, NC, USA). Qualitative data were
written down during the interview by note takers in Kiswahili (or
in English in a few cases). After translation into English, narratives
were typed in a pre-coded word processor template that reflected
interview items; this procedure followed the pre-vaccination survey
[23]. This enabled automatic importation of entire interviews with
codes into the qualitative data analysis software MAXQDA 10
(VERBI Software, Consult. Sozialforschung. GmbH, Marburg,
Germany). For integrated analysis of quantitative and qualitative
data, quantitative variables (see below) were imported into
MAXQDA 10; this made it possible to retrieve narrative segments
based on analytically relevant findings or statistical relationships.
Multivariable analysis of factors of uptake. Socio-demo-
graphic characteristics were coded as numeric or categorical
variables. Categories of socio-cultural features of cholera-like
illness were assigned a value of 2 if they were mentioned
spontaneously and a value of 1 if they were mentioned only after
probing. Those among the reported categories that were identified
as single most troubling (among patterns of distress), most
important (perceived causes) or most helpful (help seeking) were
given an additional value of 3. A cumulative prominence was then
calculated for each category ranging from 0 to 5. This approach
based on the ranked prominence of responses has been widely
used in analytic cultural epidemiological studies, which have
examined how socio-cultural features of illness affect health
behavior [32,34].
To identify social and cultural factors explaining OCV uptake, a
multivariable logistic regression model was calculated. The
outcome variable (i.e., OCV vaccination status) was obtained
from mass vaccination campaign data that had been compiled
electronically during the campaign [39]. Based on the recom-
mended schedule for DukoralH requiring two doses for full
protection, respondents who had received two doses were coded as
1 (‘‘vaccinated’’) and those who had received only one or no dose
were coded as 0 (‘‘unvaccinated’’). The regression analysis
included interaction with site as suggested by site-specific findings
from the pre-vaccination survey [24] and because OCV uptake
was higher in the rural than in the peri-urban site (58.8% vs.
40.8%, p= 0.001).
Only explanatory variables reported by 5–95% were considered
for analysis. Following the approach taken in the pre-vaccination
survey [23], variables whose univariable association with OCV
uptake had a p,0.2 were identified first. Second, multivariable
regression models related to patterns of distress, perceived causes
and help seeking were run by considering only variables that were
retained in the first step. Each of these sub-models was adjusted for
socio-demographic characteristics. To calculate the final model,
only those variables which were retained with a p,0.2 in these
sub-models were considered. Interaction between each explana-
tory variable and site (rural vs. peri-urban site at baseline) was
tested in sub-models; only interaction terms retained with a p,0.1
in sub-models were used in the final model. The final model
reports adjusted odds ratios with 95% confidence intervals and p
values. In case of significant interaction with site, site-specific
estimates are presented.
Descriptive analysis of barriers to uptake. Coding and
calculation of variables related to barriers followed the approach
used for socio-cultural features of illness. Unvaccinated respon-
dents’ spontaneous and probed answers for each barrier and the
barrier they identified as most important were recorded.
Lessons Learned to Improve OCV Community Coverage
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Thematically similar barriers were subsumed under groups of
logistical, medical and social/system-related barriers. The non-
parametric Wilcoxon test was used for identifying statistically
significant differences of prominence between both sites and
between genders.
Results
Sample characteristics
A total of 378 respondents were interviewed. Eleven interviews
were excluded from analysis due to pregnancy. Of the remaining
367 respondents, 46.6% were vaccinated with two doses, 9.3%
with one dose only and 44.1% had not drunk any dose of OCV.
Their characteristics are presented in Table 1. All respondents
were Muslims and of Tanzanian nationality.
Social and cultural factors associated with OCV uptake
Multivariable logistic regression analysis identified socio-cultural
features of cholera-like illness associated with OCV uptake,
adjusted for socio-demographic characteristics (Table 2). Among
categories of distress, two of the somatic symptoms that were
mentioned in connection with the cholera vignette were positively
associated with OCV uptake: rectal pain and loose or shriveled
skin, which is a sign of dehydration. Rectal pain was spontaneously
reported by 1.9% and mentioned by 68.7% upon probing.
Vaccinated and unvaccinated respondents explained that this
symptom meant that frequent passing of stool may be painful to
the person described in the vignette. Loose or shriveled skin was
only associated with vaccine uptake among rural respondents. It
was reported by 86.6% of the total sample; 88.8% reported it in
the rural and 84.7% in the peri-urban site and more rural
respondents mentioned it spontaneously (33.1%) compared to
peri-urban respondents (5.8%). Accounts from vaccinated and
unvaccinated respondents were similar, saying that frequent
diarrhea leads to loss of water in the body, which in turn was
seen as the reason for dehydration manifested by the sign of loose
skin.
Among categories of perceived causes, two categories were
positively associated with OCV uptake: eating food that has not
been covered properly and contact with contaminated water. The
first category was mentioned by 89.4% of the total sample and
identified by 8.2% as most important cause for cholera. Among
those who reported this category, the majority said that if food is
not covered properly, flies or other insects that carry germs may
contaminate it. A 22-year-old farmer from Pemba, who had
ingested both doses, explained it this way: ‘‘Yes, this is the area where
one can get it [the illness described in the vignette], because the flies are carrying
feces and land with it on the food.’’ Such explanations were not only
typical for the vaccinated group because narratives from
unvaccinated respondents also frequently showed flies as main
disease vector.
Fewer respondents (69.2%) reported that contact with contam-
inated water was a cause for cholera, and only 1.9% identified it as
most important cause. Both vaccinated and unvaccinated respon-
dents referred to dirty water as a potential cause because it
contains bacteria or other disease-causing organisms that can be
transmitted through the fecal-oral route. The following example
from a 19-year-old fully immunized male student from Unguja
illustrates this reasoning: ‘‘Yes, because it is already contaminated with
bacteria. If you have touched the water and not washed your hands with soap
and then you eat food you will get the disease.’’
Among categories of help seeking outside the home, consulting
pharmacies was negatively associated with OCV uptake. While
everybody reported spontaneously that a patient with cholera-like
illness should be sent to professional health facilities, 32.4% of the
sample also reported getting drugs from the pharmacy as a means
to stop diarrhea and vomiting, though none of them identified this
category as most helpful. Primarily antibiotics like tetracycline or
septrine were mentioned among both vaccinated and unvaccinat-
ed groups.
Among socio-demographic characteristics, increasing household
size and increasing age was positively related to OCV uptake. A
total of 9.5% reported a household episode of the illness described
in the cholera vignette; rural respondents reported more such
episodes than their peri-urban counterparts (13.5% vs. 5.8%,
p= 0.013). This variable was also included in the analysis and
showed a positive association with OCV uptake at the rural site.
Barriers to OCV uptake
All 196 respondents who were not completely immunized were
asked the following open question: ‘‘Can you tell us the reasons
why you did not swallow two doses of the cholera vaccine?’’
Individual and grouped barriers are presented for the overall sub-
sample of unvaccinated respondents (Table 3), and stratified by
site (Table 4) and by gender (Table 5).
Most prominent barriers. Logistical factors were reported
as paramount barriers, followed by medical issues; social and
system-related factors were the least prominent barriers (Table 3).
The most prominent individual barrier to OCV uptake (i.e., the
one having the highest mean prominence) was competing obligations
or priorities, which was reported by almost three-quarters (74.5%) of
the unvaccinated respondents and identified by nearly half (49.5%)
as the most important barrier. Analysis of qualitative data from
these respondents indicated that they had mostly been away for a
longer time on the mainland or another island and thus were less
able to reach the vaccination posts. Activities included working in
farms, going on month-long fishing trips and some visited their
relatives or were away from home for study or exams.
The second most prominent barrier was lacking information about
the campaign, reported by 29.6% and identified as most important
barrier by 12.2%. Almost everyone who did not have information
about the campaign also reported his/her absence because of
other activities. The following accounts illustrate how lacking
information and being away together prevented vaccine uptake.
Respondents were either away during both rounds, as illustrated
by the account of a 36-year-old man from Chumbuni: ‘‘I was not
here during the campaign and I didn’t know when the campaign started and
finished. I am a seaman. My wife informed me that all the people in the house
got the vaccine. The day I arrived here I was advised to take the vaccine but I
didn’t take it because I was tight with other activities. And on the second day
my boss asked me to go to Mombasa.’’ Or they were only in their village
during the second round, but not given the vaccine: ‘‘I was not
around because I had traveled to Wete. And when I came back I went to the
vaccination post and the workers told me that I cannot get it because I missed
the first dose.’’ (Housewife from Mwambe, 50 years old)
Sickness, which was reported by 14.3% of unvaccinated
respondents in total and identified by 13.3% as the single most
important reason, was the third most prominent barrier to uptake.
Respondents who reported a sickness were either uncomfortable to
take the vaccine, concerned about a potential negative impact of
vaccination on their health, or simply not able to access
vaccination posts because of a physical handicap or a recent
delivery or surgery.
Fear of possible side effects was the fourth most prominent barrier
against vaccination, reported by 15.3% in total and identified by
5.6% as most important. People were afraid of side effects such as
diarrhea, vomiting, nausea, skin reactions after injection, and
exacerbations of underlying diseases due to interaction with the
Lessons Learned to Improve OCV Community Coverage
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vaccine. Also, something free of charge was believed to cause
problems. Three respondents were afraid of side effects if the
vaccine was administered concurrently with other drugs—they
were also among those who reported being sick as main barrier to
vaccination.
Besides fear of side effects, doubted effectiveness of the vaccine was
reported by 9.2% as another vaccine-related barrier; and for 4.6%
this category was the main reason against taking the OCV.
Respondents were not sure about the benefit for their own health
or the effectiveness of the vaccine.
Least prominent barriers. The four least prominent
barriers to OCV uptake were related to lacking confidence in the
government (reported in total by 2.6% of the unvaccinated sub-
sample), costs apart from the vaccine (3.6%), prior bad experience with health
system (0.5%), and organizational problems at vaccination post (0.5%)
(Table 3).
Other barriers related to social issues were reported by 5% or
less: mistrust motives of the campaign were reported by 5.1% and social
pressure against vaccination and fear of infertility by 3.1%. Nobody
Table 1. Socio-demographic characteristics and vaccination status of a sample interviewed after a community mass vaccination
campaign in Zanzibar, stratified by site and gender.
Total Peri-urban site Rural site Women Men
Number (%) 367 (100) 189 (51.5) 178 (48.5) 180 (49.0) 187 (51.0)
Age (years)
Mean (SD) 35.4 (14.6) 33.1 (13.5) 37.8 (15.4) ** 35.7 (13.8) 35.1 (15.4)
Median (range) 32 (18–90) 28 (18–75) 36.5 (18–90) ** 33 (18–90) 30 (18–80)
Marital status (%)
Never married 30.5 42.9 17.4 *** 21.1 39.6 ***
Married 59.4 49.7 69.7 *** 61.1 57.8
Separated 0.5 0.0 1.1 0.0 1.1
Divorced 6.5 6.9 6.2 12.2 1.1 ***
Widowed 3.0 0.5 5.6 ** 5.6 0.5 **
Household size (number of persons)
Mean (SD) 6.9 (3.0) 7.6 (3.2) 6.3 (2.6) *** 6.8 (3.0) 7.1 (2.9)
Median (range) 7 (1–15) 7 (1–15) 6 (1–13) *** 7 (1–14) 7 (1–15)
Main occupation (%)
Agriculture 30.8 3.2 60.1 *** 35.0 26.7
Fishing 6.0 0.0 12.4 *** 0.0 11.8 ***
Self-employment 23.7 36.0 10.7 *** 18.3 28.9 *
Formal employment 8.2 13.2 2.8 *** 3.3 12.8 ***
Housewife 12.3 18.0 6.2 *** 25.0 0.0 ***
Casual laborer 0.8 1.1 0.6 0.0 1.6
Student 12.5 18.0 6.7 ** 12.2 12.8
Not active/retired 5.7 10.6 0.6 *** 6.1 5.3
Highest education (%)
No education 8.4 4.8 12.4 * 10.6 6.4
Koranic school 23.7 10.1 38.2 *** 30.6 17.1 **
Primary school 26.4 21.2 32.0 * 19.4 33.2 **
Secondary school 36.8 56.1 16.3 *** 35.6 38.0
Above secondary school 4.6 7.9 1.1 ** 3.9 5.3
Vocational school 1.4 1.6 1.1 0.6 2.1
Higher education 3.3 6.3 0.0 *** 3.3 3.2
Household income (%)
More regular and dependable 39.8 54.0 24.7 *** 41.1 38.5
Less regular and dependable 60.2 46.0 75.3 58.9 61.5
Vaccination status
Receipt of 2 doses, number (%) 171 (46.6) 86 (45.5) 85 (47.8) 85 (47.2) 86 (46.0)
Receipt of 1 dose, number (%) 34 (9.3) 18 (9.5) 16 (9.0) 17 (9.4) 17 (9.1)
Receipt of 0 doses, number (%) 162 (44.1) 85 (45.0) 77 (43.3) 78 (43.3) 84 (44.9)
SD: Standard deviation, t test used for comparing means, Wilcoxon test used for comparing medians, Fisher’s exact test used for comparing proportions (*p,0.05,
**p,0.01, ***p,0.001).
doi:10.1371/journal.pone.0041527.t001
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reported that discouragement by authoritative persons made them
refuse vaccination.
Site- and gender-specific barriers. Among the most
prominent barriers, lacking information about the campaign was more
often reported and identified as most important barrier among
rural than peri-urban respondents (p = 0.012) (Table 4). Narratives
indicated that rural respondents were away from their homes for
longer times and several went fishing for months, which made it
difficult for them to be home at the right time slot needed for the
vaccination: ‘‘I had traveled to Unguja for fishing for a period of one month
and fifteen days. And I had no information about the vaccine campaign.’’
(Unvaccinated rural fisherman, 35 years old)
Four more barriers were more prominent in the rural area:
limited open days/hours of vaccination post (p = 0.045), vaccine free of charge
is useless (p = 0.020), mistrust motives of the campaign (p = 0.037) and
lacking confidence in government (p = 0.019). Three out of these five
rural barriers were also reported with more prominence by men
(in the total sub-sample): Limited open days/hours of vaccination
post (p = 0.032), vaccine free of charge is useless (p = 0.008) and lacking
confidence in government (p = 0.030).
The analysis of grouped categories showed that men reported
significantly more logistical, social and system-related barriers than
women (Table 5). Narratives indicated that men had their business
or were committed to fishing and farming and mostly away during
the daytime or for months. These commitments limited access to
vaccination posts because open hours were too limited or because
the duration of the campaign itself was not long enough. Even
though women reported fewer such problems, they also explained
their absence as being too busy with work and thus unable to reach
the posts in time. Mostly rural men, compared to only one woman
from the peri-urban site, complained about why the vaccine was
offered free of charge despite the fact that other drugs require
purchase. This and the finding that only rural men were not
confident about the government’s intentions is illustrated by the
account of a 40-year-old man from Pemba: ‘‘I did not drink the
medicine because I felt it does not help and drugs are not given free. Also when
they give it to you free of charge there is some reason for doing that.’’
Sickness was equally prominent in both sites, but the majority
who reported this barrier were women (26.3% vs. 3.0%, p,0.001).
Qualitative data showed that many of those women had actually
been eager to receive the vaccine, but could not because of
troubling symptoms or because they were afraid that the vaccine
could make their present condition worse. A 30-year-old housewife
from Chumbuni explained why she could not take the vaccine
because of her severe fever: ‘‘I came home during the vaccination days but
I had severe fever and I left soon after the campaign. While I was there I heard
an announcement about the vaccination on the radio. But because of my
condition—I was still sick—I was unable to come and take the vaccine.’’
Three men only reported sickness, but identified it as the most
important barrier; they exclusively referred to a perceived harmful
interaction between drugs and the OCV: ‘‘I was sick with severe fever.
And they told me it was [high blood] pressure. I was using many drugs and
therefore I was told not to mix drugs because of harmful effects.’’ (50-year-old
farmer in Mwambe)
Since the majority of respondents (76.5%) had missed the
vaccination due to logistical constraints (Table 3), further analysis
of their views was deemed necessary. At the end of the interview,
respondents were encouraged to share any additional comments,
advice or suggestions about the health problems and vaccines that
had been discussed or needed to be emphasized. Based on the
assumption that these respondents did not object to receiving the
OCV in principle, thematic analysis of their concluding statements
was done.
Most of the respondents who missed the complete course of
vaccination because of logistical barriers requested the govern-
ment repeat the vaccination to make them fully immunized and to
vaccinate those people who did not get the vaccine during the
campaign. They also emphasized the need to make the vaccine
available free of charge and frequently demanded more health
education in the communities. Even though men reported
logistical barriers more prominently (Table 5), themes identified
in male and female narratives were very similar. A businessman
from Chumbuni, aged 28 years, gave the following advice: ‘‘I would
like to advise the Ministry of Health to provide free vaccines. They should also
sensitize the community by providing health education. This will make the
community aware of the importance of vaccines.’’ A female student from
Mwambe, aged 18 years, also suggested how to improve the
campaign: ‘‘The vaccination should be repeated so that I can also make it.
But I suggest that we should be better informed about the real date of the second
dose.’’
Because campaign implementers had paid attention to mini-
mize accessibility-related barriers, issues of distance to vaccination
posts were not specifically elicited as potential barrier. Thematic
analysis of accounts of unvaccinated respondents did not reveal
that difficulties with travel to reach the vaccination posts may have
been a problem, thereby corroborating this assumption.
Table 2. Social and cultural factors associated with oral
cholera vaccine uptake in a community mass vaccination
campaign in Zanzibar, n = 367.
Adjusted analysisa
ORb 95% CIc p valued Inte
Categories of distress: somatic symptoms
Pus in stool 1.35 0.87 2.11 0.178
Rectal pain 1.83 1.17 2.86 0.008
Sunken eyes 1.20 0.86 1.67 0.289
Loose skin (peri-urban site) 0.62 0.32 1.20 0.157
Loose skin (rural site) 2.00 1.18 3.40 0.010 **
Perceived causes
Unprotected/spoiled food 1.24 1.00 1.54 0.049
Contact with contaminated water 1.43 1.06 1.92 0.019
Outside help seeking
Pharmacy/Over-the-counter drugs 0.55 0.34 0.88 0.013
Socio-demographics and previous illness
episode
Age 1.03 1.01 1.04 0.002
Household size 1.09 1.01 1.18 0.028
Site (rural vs. peri-urban) 0.28 0.10 0.77 0.014
Previous enteric illness episode (peri-urban
site)
0.69 0.18 2.65 0.586
Previous enteric illness episode (rural site) 3.03 1.13 8.09 0.027 *
aList of variables with univariable association with vaccine uptake at p,0.2 that
were included in adjusted models. Gender, a matching variable, was not
included as a main factor because its p value was above 0.2; site was included
for interaction testing (see footnote e);
bAdjusted odds ratio;
c95% Confidence interval;
dFigures in bold if p,0.05;
eInteraction of site (rural with peri-urban baseline) was considered if the p value
of the interaction term was less than 0.1 (*p,0.1, **p,0.01).
doi:10.1371/journal.pone.0041527.t002
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Discussion
This post-vaccination survey clarified social and cultural factors
of uptake of an oral cholera vaccine in a peri-urban and a rural
community of Zanzibar. Socio-cultural features of cholera-like
illness and socio-demographic factors were identified, and
logistical, medical and social and system-related barriers were
examined among unvaccinated community residents.
Influence of social and cultural factors on uptake
Compared to the pre-vaccination analysis of determinants of
OCV uptake where nonspecific symptoms of cholera determined
uptake negatively, rectal pain was positively associated with OCV
uptake in this survey. Even though cholera-related purging is
usually painless [4], this finding may indicate a priority for
vaccines not only for cholera but also for severe diarrhea in
general. Features of dehydration were identified as promoting
factors for vaccination in both pre- and post-vaccination surveys.
However, while unconsciousness determined uptake positively in
the pre-vaccination study in both sites, reporting a loose or
shriveled skin influenced only rural respondents to take the OCV.
Recognizing biomedical risk factors for cholera (i.e., the
potential risk for infection with germs when leaving food
uncovered or when coming into contact with contaminated water)
prompted respondents to take the OCV. This may reflect the
positive impact of the mass vaccination campaign on people’s
ideas and behavior. Neither biomedical nor alternative factors that
had been perceived to cause cholera were identified as determi-
nants of OCV uptake in the pre-vaccination survey.
Even though the OCV was offered for free during the campaign
and no considerable direct costs were likely to be incurred in
accessing the vaccination posts, purchasing drugs in pharmacies to
stop vomiting and diarrhea competed with vaccines. This finding
may indicate that the idea of treating cholera with drugs seemed to
be more attractive than prevention with vaccination, or that the
appeal of well-known powerful antibiotics was so valued that they
overrode vaccination as a new and more uncertain intervention for
cholera in Zanzibar.
Reporting a previous enteric illness episode at the rural site was
positively associated with uptake. This confirms results from a
study in Vietnam [11], but contrasts the pre-vaccination study in
Zanzibar, where reporting of such episodes did not determine
vaccine uptake. This finding nevertheless suggests a higher
perceived need for vaccination in the rural area, which is
supported by the higher OCV uptake among rural respondents
and the finding from the pre-vaccination study that fear of
disruptions of healthcare services during cholera outbreaks was a
positive determinant of OCV uptake in the rural area. Consistent
Table 3. Barriers to uptake of an oral cholera vaccine in a community mass vaccination campaign in Zanzibar.
Pooled sample, n =196
How reported?
Barriers to uptakea Totalb % Spontaneousc % Most importantd % Mean prom.e
Logistical barriers 76.5 71.4 63.3 3.38
Competing obligations/priorities 74.5 69.4 49.5 2.92
Lacking information about campaign 29.6 9.7 12.2 0.76
Vaccination post open days/hours limited 13.8 3.1 1.5 0.21
Costs apart from vaccine 3.6 0.5 0.0 0.04
Organizational problems at vaccination post 0.5 0.0 0.0 0.01
Medical barriers 31.1 23.5 23.5 1.25
I was sick (not due to vaccine) 14.3 14.3 13.3 0.68
Fear of possible side effects from vaccine 15.3 6.1 5.6 0.38
Doubted effectiveness of vaccine 9.2 5.6 4.6 0.29
Social/system-related barriers 12.2 4.1 3.6 0.27
Vaccine free of charge (useless medicine) 5.6 2.6 1.0 0.11
Fear of infertility 3.1 0.0 1.5 0.08
Mistrust motives of campaign 5.1 2.0 0.0 0.07
Social pressure against taking vaccine 3.1 1.0 0.5 0.06
Lacking confidence in government 2.6 1.0 0.5 0.05
Prior bad experience with health system 0.5 0.0 0.0 0.01
Miscellaneous 8.7 8.7 6.6 0.37
Other barriers 7.1 7.1 5.6 0.31
Cannot say/Nothing 1.5 1.5 1.0 0.06
aBarriers ordered according to descending mean prominence (see footnote e), grouped barriers in bold;
bPercentage of barriers reported spontaneously and after probing;
cPercentage of barriers reported spontaneously only;
dPercentage of barriers that were identified as single most important among all the reported barriers. Six respondents who only received one dose identified barriers
that were not among the ones listed as most important: four respondents reported ‘‘Experience of side effects from first dose of vaccine,’’ two respondents reported
‘‘Did not have information about timing of second dose;’’
eMean prominence based on values assigned for each barrier (3 = identified as most important, 2 = reported spontaneously, 1 = reported after probing, 0 = not
reported).
doi:10.1371/journal.pone.0041527.t003
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with the pre-vaccination study is the finding that older people were
more likely to drink the OCV. A higher household size, which had
made people less willing to pay for an OCV before the campaign,
was positively associated with uptake; this might demonstrate the
higher perceived need for vaccines if no costs are attached to it.
Assessment of barriers to uptake
Logistical issues were paramount barriers against taking the
vaccine. Issues around social pressure or mistrust in the
government or the vaccine, which have been identified as major
factors against cholera control [41] or vaccination in other
developing countries [17,42], did influence campaign coverage in
Zanzibar only slightly. The importance of logistical issues confirms
findings from a mass vaccination campaign in the cholera-endemic
city of Beira, Mozambique, where main reason against OCV
uptake were traveling (mentioned by 58% of non-acceptors) and
being busy (26%), while the rest reported pregnancy (5.2%),
refusal (3.7%), long waiting time (3.1%) and taking medication
(2.6%) [8].
People’s own busy daily schedules and obligations, which made
it also less likely for them to receive timely information about the
planned mass vaccination campaign, were limiting factors to
receive vaccines. Qualitative data clearly indicate that those
residents who had been away during the campaign still wished to
receive the vaccine. Thus, it can be expected that an earlier start of
the mobilization—media broadcasts and meetings with commu-
nity leaders started only shortly before the campaign in January
2009—is likely to increase coverage because people would have
more time to plan their activities around the campaign.
Alternative ways to administer the vaccine may have to be
considered as well to better reach those population groups that are
in principal willing to get vaccinated but whose daily schedules or
professional activities make it difficult to receive vaccines.
Fears about possible side effects were a substantive barrier to
uptake; this needs to be addressed in future campaigns. The
usually mild and transient side effects of DukoralH (or other OCVs)
[7,38] should be explained more properly versus the benefit of
protection against cholera. Such information may also re-
emphasize that the vaccine is administered orally and not through
injections.
Rumors about sterility have been reported in many immuni-
zation campaigns in Africa [43]. However, contrary to studies
reporting that Muslims believe vaccines might cause infertility or
could have been adulterated with anti-fertility agents [42–44],
issues around fertility were not an important barrier to vaccine
uptake. This suggests that future cholera campaigns in Zanzibar
Table 4. Barriers to uptake of an oral cholera vaccine in a community mass vaccination campaign in Zanzibar, stratified by site.
Peri-urban site, n= 103 Rural site, n = 93
How reported? How reported?
Barriers to uptakea Totalb % Spontaneousc %
Most
importantd
%
Mean
prom.e Totalb % Spontaneousc %
Most
importantd
%
Mean
prom.e
Logistical barriers 79.6 75.7 68.0 3.59 73.1 66.7 58.1 3.14
Competing obligations/priorities 76.7 73.8 55.3 3.17 72.0 64.5 43.0 2.66
Lacking information about campaign 20.4 8.7 11.7 0.64 39.8 10.8 12.9 0.89
Vaccination post open days/hours limited 8.7 4.9 1.0 0.17 19.4 1.1 2.2 0.27
Costs apart from vaccine 2.9 0.0 0.0 0.03 4.3 1.1 0.0 0.05
Organizational problems at vaccination post 0.0 0.0 0.0 0.00 1.1 0.0 0.0 0.01
Medical barriers 27.2 22.3 23.3 1.19 35.5 24.7 23.7 1.31
I was sick (not due to vaccine) 15.5 15.5 14.6 0.75 12.9 12.9 11.8 0.61
Fear of possible side effects from vaccine 10.7 4.9 5.8 0.33 20.4 7.5 5.4 0.44
Doubted effectiveness of vaccine 5.8 3.9 2.9 0.18 12.9 7.5 6.5 0.40
Social/system-related barriers 8.7 2.9 1.0 0.15 16.1 5.4 6.5 0.41
Vaccine free of charge (useless medicine) 1.9 1.0 0.0 0.03 9.7 4.3 2.2 0.20
Fear of infertility 1.9 0.0 0.0 0.02 4.3 0.0 3.2 0.14
Mistrust motives of campaign 1.9 1.0 0.0 0.03 8.6 3.2 0.0 0.12
Social pressure against taking vaccine 3.9 1.9 1.0 0.09 2.2 0.0 0.0 0.02
Lacking confidence in government 0.0 0.0 0.0 0.00 5.4 2.2 1.1 0.11
Prior bad experience with health system 0.0 0.0 0.0 0.00 1.1 0.0 0.0 0.01
Miscellaneous 6.8 6.8 5.8 0.31 10.8 10.8 7.5 0.44
Other barriers 5.8 5.8 4.9 0.26 8.6 8.6 6.5 0.37
Cannot say/Nothing 1.0 1.0 1.0 0.05 2.2 2.2 1.1 0.08
aBarriers ordered according to descending mean prominence for the pooled sample (see Table 3), grouped barriers in bold;
bPercentage of barriers reported spontaneously and after probing;
cPercentage of barriers reported spontaneously only;
dPercentage of barriers that were identified as single most important among all the reported barriers;
eMean prominence based on values assigned for each barrier (3 = identified as most important, 2 = reported spontaneously, 1 = reported after probing, 0 = not
reported), *p,0.05 (Wilcoxon test for comparison of mean prominence between site).
doi:10.1371/journal.pone.0041527.t004
Lessons Learned to Improve OCV Community Coverage
PLoS ONE | www.plosone.org 8 July 2012 | Volume 7 | Issue 7 | e41527
T
a
b
le
5
.
B
ar
ri
e
rs
to
u
p
ta
ke
o
f
an
o
ra
l
ch
o
le
ra
va
cc
in
e
in
a
co
m
m
u
n
it
y
m
as
s
va
cc
in
at
io
n
ca
m
p
ai
g
n
in
Z
an
zi
b
ar
,
st
ra
ti
fi
e
d
b
y
g
e
n
d
e
r.
W
o
m
e
n
,
n
=
9
5
M
e
n
,
n
=
1
0
1
H
o
w
re
p
o
rt
e
d
?
H
o
w
re
p
o
rt
e
d
?
B
a
rr
ie
rs
to
u
p
ta
k
e
a
T
o
ta
lb
%
S
p
o
n
ta
n
e
o
u
sc
%
M
o
st
im
p
o
rt
a
n
td
%
M
e
a
n
p
ro
m
.e
T
o
ta
lb
%
S
p
o
n
ta
n
e
o
u
sc
%
M
o
st
im
p
o
rt
a
n
td
%
M
e
a
n
p
ro
m
.e
Lo
g
is
ti
ca
l
b
ar
ri
e
rs
6
6
.3
6
2
.1
5
6
.8
2
.9
9
8
6
.1
8
0
.2
6
9
.3
3
.7
4
*
C
o
m
p
e
ti
n
g
o
b
lig
at
io
n
s/
p
ri
o
ri
ti
e
s
6
5
.3
6
1
.1
4
7
.4
2
.6
8
8
3
.2
7
7
.2
5
1
.5
3
.1
5
La
ck
in
g
in
fo
rm
at
io
n
ab
o
u
t
ca
m
p
ai
g
n
2
6
.3
7
.4
8
.4
0
.5
9
3
2
.7
1
1
.9
1
5
.8
0
.9
2
V
ac
ci
n
at
io
n
p
o
st
o
p
e
n
d
ay
s/
h
o
u
rs
lim
it
e
d
8
.4
1
.1
1
.1
0
.1
3
1
8
.8
5
.0
2
.0
0
.3
0
*
C
o
st
s
ap
ar
t
fr
o
m
va
cc
in
e
2
.1
0
.0
0
.0
0
.0
2
5
.0
1
.0
0
.0
0
.0
6
O
rg
an
iz
at
io
n
al
p
ro
b
le
m
s
at
va
cc
in
at
io
n
p
o
st
0
.0
0
.0
0
.0
0
.0
0
1
.0
0
.0
0
.0
0
.0
1
M
e
d
ic
al
b
ar
ri
e
rs
3
8
.9
3
2
.6
3
2
.6
1
.6
9
2
3
.8
1
4
.9
1
4
.9
0
.8
3
**
I
w
as
si
ck
(n
o
t
d
u
e
to
va
cc
in
e
)
2
6
.3
2
6
.3
2
4
.2
1
.2
5
3
.0
3
.0
3
.0
0
.1
5
**
*
Fe
ar
o
f
p
o
ss
ib
le
si
d
e
e
ff
e
ct
s
fr
o
m
va
cc
in
e
1
5
.8
6
.3
5
.3
0
.3
8
1
4
.9
5
.9
5
.9
0
.3
9
D
o
u
b
te
d
e
ff
e
ct
iv
e
n
e
ss
o
f
va
cc
in
e
5
.3
3
.2
3
.2
0
.1
8
1
2
.9
7
.9
5
.9
0
.3
9
S
o
ci
al
/s
ys
te
m
-r
e
la
te
d
b
ar
ri
e
rs
7
.4
0
.0
1
.1
0
.1
1
1
6
.8
7
.9
5
.9
0
.4
3
*
V
ac
ci
n
e
fr
e
e
o
f
ch
ar
g
e
(u
se
le
ss
m
e
d
ic
in
e
)
1
.1
0
.0
0
.0
0
.0
1
9
.9
5
.0
2
.0
0
.2
1
**
Fe
ar
o
f
in
fe
rt
ili
ty
2
.1
0
.0
1
.1
0
.0
5
4
.0
0
.0
2
.0
0
.1
0
M
is
tr
u
st
m
o
ti
ve
s
o
f
ca
m
p
ai
g
n
2
.1
0
.0
0
.0
0
.0
2
7
.9
4
.0
0
.0
0
.1
2
So
ci
al
p
re
ss
u
re
ag
ai
n
st
ta
ki
n
g
va
cc
in
e
3
.2
0
.0
0
.0
0
.0
3
3
.0
2
.0
1
.0
0
.0
8
La
ck
in
g
co
n
fi
d
e
n
ce
in
g
o
ve
rn
m
e
n
t
0
.0
0
.0
0
.0
0
.0
0
5
.0
2
.0
1
.0
0
.1
0
*
P
ri
o
r
b
ad
e
xp
e
ri
e
n
ce
w
it
h
h
e
al
th
sy
st
e
m
0
.0
0
.0
0
.0
0
.0
0
1
.0
0
.0
0
.0
0
.0
1
M
is
ce
ll
an
e
o
u
s
9
.5
9
.5
7
.4
0
.4
1
7
.9
7
.9
5
.9
0
.3
4
O
th
e
r
b
ar
ri
e
rs
8
.4
8
.4
6
.3
0
.3
6
5
.9
5
.9
5
.0
0
.2
7
C
an
n
o
t
sa
y/
N
o
th
in
g
1
.1
1
.1
1
.1
0
.0
5
2
.0
2
.0
1
.0
0
.0
7
a
B
ar
ri
e
rs
o
rd
e
re
d
ac
co
rd
in
g
to
d
e
sc
e
n
d
in
g
m
e
an
p
ro
m
in
e
n
ce
fo
r
th
e
p
o
o
le
d
sa
m
p
le
(s
e
e
T
ab
le
3
),
g
ro
u
p
e
d
b
ar
ri
e
rs
in
b
o
ld
;
b
P
e
rc
e
n
ta
g
e
o
f
b
ar
ri
e
rs
re
p
o
rt
e
d
sp
o
n
ta
n
e
o
u
sl
y
an
d
af
te
r
p
ro
b
in
g
;
c
P
e
rc
e
n
ta
g
e
o
f
b
ar
ri
e
rs
re
p
o
rt
e
d
sp
o
n
ta
n
e
o
u
sl
y
o
n
ly
;
d
P
e
rc
e
n
ta
g
e
o
f
b
ar
ri
e
rs
th
at
w
e
re
id
e
n
ti
fi
e
d
as
si
n
g
le
m
o
st
im
p
o
rt
an
t
am
o
n
g
al
l
th
e
re
p
o
rt
e
d
b
ar
ri
e
rs
;
e
M
e
an
p
ro
m
in
e
n
ce
b
as
e
d
o
n
va
lu
e
s
as
si
g
n
e
d
fo
r
e
ac
h
b
ar
ri
e
r
(3
=
id
e
n
ti
fi
e
d
as
m
o
st
im
p
o
rt
an
t,
2
=
re
p
o
rt
e
d
sp
o
n
ta
n
e
o
u
sl
y,
1
=
re
p
o
rt
e
d
af
te
r
p
ro
b
in
g
,
0
=
n
o
t
re
p
o
rt
e
d
),
*p
,
0
.0
5
,
**
p
,
0
.0
1
,
**
*p
,
0
.0
0
1
(W
ilc
o
xo
n
te
st
fo
r
co
m
p
ar
is
o
n
o
f
m
e
an
p
ro
m
in
e
n
ce
b
e
tw
e
e
n
g
e
n
d
e
r)
.
d
o
i:1
0
.1
3
7
1
/j
o
u
rn
al
.p
o
n
e
.0
0
4
1
5
2
7
.t
0
0
5
Lessons Learned to Improve OCV Community Coverage
PLoS ONE | www.plosone.org 9 July 2012 | Volume 7 | Issue 7 | e41527
are somewhat less likely to suffer from such potentially sensitive
issues.
The site and gender analysis of barriers to uptake showed that
logistical challenges to access vaccination posts, and a tendency to
question the value of vaccination against cholera, were primarily
prominent among rural men. Despite differing logistical challeng-
es, a clear demand for OCVs or a repetition of the mass
vaccination campaign was reported among both genders, high-
lighting the local priority and demand for vaccination for cholera
control in endemic areas of Zanzibar. Because sickness prevented
more than one-fourth of women (regardless of site) from accessing
posts or accepting the vaccine, further study may be needed to
examine whether women are in general more often sick than men
in Zanzibar, or whether this gender difference occurred by chance.
This study used an approach that is broadly applicable for
assessing locally relevant socio-cultural features (and barriers) of
vaccine acceptance in cholera-endemic areas. Because cholera
control (and other disease control activities) requires consideration
of local contexts, it cannot be expected that all findings are
applicable locally in all other settings, even if some of them may
be. It should also be borne in mind that this was a cross-sectional
survey, where only associations and no causal relationships could
be examined.
Lessons learned and recommendations
Despite a high willingness to receive free vaccines, coverage was
less than satisfying in the 2009 oral cholera mass vaccination
campaign in Zanzibar. Complementing a pre-vaccination com-
munity survey that identified predisposing social and cultural
factors as determinants of OCV uptake, this post-vaccination
survey examined which social and cultural factors were associated
with uptake and assessed barriers to uptake among unvaccinated
community residents.
Factors associated with uptake indicated a positive impact of the
mass vaccination campaign and of community sensitization
activities on vaccine acceptance behavior. Unlike in other
circumstances, where communities opposed cholera control or
where public trust of vaccines was damaged, the evaluation of
barriers to uptake also indicated a good implementation of the
mass vaccination campaign and trust in the health system.
High community awareness of cholera and a positive attitude
towards receiving OCVs, especially if they are provided without
charge, suggest little opposition to vaccination as a supplementary
means to cholera control in Zanzibar. Despite such encouraging
prospects and demand for repeating vaccination in cholera-
endemic populations, local decision-makers and public health
officials still need to know how community coverage of mass
campaigns could be improved. Even though the following
recommendations are in principle limited to cholera-endemic
communities in Zanzibar, national and international cholera
control experts may also benefit from them, and focus groups may
be useful to guide implementation of these recommendations.
First, campaigns should be announced earlier, at least a few
months before vaccination posts open, with repeated reminders in
the target communities. Second, campaign planners may also
consider an extension of daily open hours or numbers of days for
the vaccination especially in rural areas. Third, information about
the campaign should not only cover dates and venues, specific
requirements and inclusion criteria, but, fourth, also reinforce
again more general health education on hygiene and diarrhea to
interrupt fecal-oral transmission and, fifth, particularly point out
the value of vaccination versus treatment of cholera with
antibiotics. Sixth, although side effects of OCVs are usually mild,
they should not only be specified, but also explained versus the
benefit of vaccination. Finally, identification of alternative
solutions to mass vaccination campaigns may be needed for
population groups that recognize the value of vaccination in
principal but are harder to reach due to their daily or professional
activities.
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